Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-15-364232
Filing Date
2015-11-03
Accepted
2015-11-03 15:47:28
Documents
11
Period of Report
2015-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d19030d10q.htm 10-Q 559887
2 EXHIBIT 31.1 d19030dex311.htm EX-31.1 8407
3 EXHIBIT 31.2 d19030dex312.htm EX-31.2 8411
4 EXHIBIT 32.1 d19030dex321.htm EX-32.1 4500
5 EXHIBIT 32.2 d19030dex322.htm EX-32.2 4505
  Complete submission text file 0001193125-15-364232.txt   3107399

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT nstg-20150930.xml EX-101.INS 482383
7 XBRL TAXONOMY EXTENSION SCHEMA nstg-20150930.xsd EX-101.SCH 36288
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE nstg-20150930_cal.xml EX-101.CAL 71138
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nstg-20150930_def.xml EX-101.DEF 116130
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE nstg-20150930_lab.xml EX-101.LAB 296624
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nstg-20150930_pre.xml EX-101.PRE 220605
Mailing Address 530 FAIRVIEW AVENUE NORTH SUITE 2000 SEATTLE WA 98109
Business Address 530 FAIRVIEW AVENUE NORTH SUITE 2000 SEATTLE WA 98109 206-378-6266
NanoString Technologies Inc (Filer) CIK: 0001401708 (see all company filings)

EIN.: 200094687 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35980 | Film No.: 151193614
SIC: 2836 Biological Products, (No Diagnostic Substances)